Inhibition of inflammation but not ankylosis by glucocorticoids in mice: Further evidence for the entheseal stress hypothesis

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Braem, Kirsten ^a   Deroose, Christophe M ^b   Luyten, Frank P ^a,b   Lories, Rik J ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; BMP2 PROTEIN, MOUSE; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANKYLOSIS; ARTHRITIS; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPOTHESIS; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE; MALE; MESENCHYME CELL; MOUSE; NEUTROPHIL; NONHUMAN; OSTEOLYSIS; PERIOSTEUM; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; AGING; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; DBA MOUSE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

AGING; ANIMALS; ANKYLOSIS; ARTHRITIS, EXPERIMENTAL; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; CELLS, CULTURED; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED DBA; STRESS, PHYSIOLOGICAL;

EID: 84857990743     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3772     Document Type: Article

References (30)

1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, . National Arthritis Data Workgroup Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum 2008, 58:15-25. 10.1002/art.23177, 18163481, National Arthritis Data Workgroup.
2. Braun J, Sieper J. Ankylosing spondylitis. The Lancet 2007, 369:1379-1390.
3. Machado P, Landewé R, Braun J, Hermann K-GA, Baker D, van der Heijde D. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis 2010, 69:1465-1470. 10.1136/ard.2009.124206, 20498215.
4. Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int 2011, 22:421-433. 10.1007/s00198-010-1319-x, 21574050.
5. Carter S, Lories R. Osteoporosis: a paradox in ankylosing spondylitis. Current Osteoporosis Rep 2011, 9:112-115.
6. Lories R, Luyten F, de Vlam K. Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther 2009, 11:221. 10.1186/ar2642, 2688182, 19439035.
7. Lories RJU, Derese I, de Bari C, Luyten FP. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 2007, 56:489-497. 10.1002/art.22372, 17265484.
8. van der Heijde D, Landewé R, Baraliakos X, Houben H, Tubergen A, Williamson P, Xu W, Baker D, Goldstein N, Braun J. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008, 58:3063-3070. 10.1002/art.23901, 18821688.
9. van der Heijde D, Landewé R, Einstein S, Ory P, Vosse D, Ni L, Lin SL, Tsuji W, Davis JC. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 2008, 58:1324-1331. 10.1002/art.23471, 18438853.
10. van der Heijde D, Salonen D, Weissman B, Landewe R, Maksymowych W, Kupper H, Ballal S, Gibson E, Wong R, , . Canadian (M03-606) study group, ATLAS study group Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 2009, 11:R127. 10.1186/ar2794, 2745811, 19703304, Canadian (M03-606) study group, ATLAS study group.
11. Sieper J, Appel H, Braun J, Rudwaleit M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 2008, 58:649-656. 10.1002/art.23260, 18311819.
12. Lories RJU, de Vlam K, Luyten FP. Are current available therapies disease-modifying in spondyloarthritis?. Best Pract Res Clin Rheumatol 2010, 24:625-635. 10.1016/j.berh.2010.05.005, 21035084.
13. Lories RJU, Matthys P, de Vlam K, Derese I, Luyten FP. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis 2004, 63:595-598. 10.1136/ard.2003.013599, 1754976, 15082495.
14. Lories RJU, Derese I, Luyten FP. Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis. Rheumatology (Oxford) 2008, 47:605-608.
15. Lories RJU, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005, 115:1571-1579. 10.1172/JCI23738, 1090472, 15902307.
16. Corthay A, Hansson A-S, Holmdahl R. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum 2000, 43:844-851. 10.1002/1529-0131(200004)43:4<844::AID-ANR15>3.0.CO;2-B, 10765929.
17. Loening A, Gambhir S. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging 2003, 2:131-137. 10.1162/153535003322556877, 14649056.
18. Lories RJU, Peeters J, Bakker A, Tylzanowski P, Derese I, Schrooten J, Thomas JT, Luyten FP. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum 2007, 56:4095-4103. 10.1002/art.23137, 18050203.
19. Roberts SJ, Geris L, Kerckhofs G, Desmet E, Schrooten J, Luyten FP. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials 2011, 32:4393-4405. 10.1016/j.biomaterials.2011.02.047, 21421268.
20. Chuah MKL, Van Damme A, Zwinnen H, Goovaerts I, Vanslembrouck V, Collen D, Vandendriessche T. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. Hum Gene Ther 2000, 11:729-738. 10.1089/10430340050015626, 10757352.
21. Kaim AH, Weber B, Kurrer MO, Gottschalk J, von Schulthess GK, Buck A. Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology 2002, 223:446-451. 10.1148/radiol.2232010914, 11997551.
22. Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, Yamane S, Suzuki R, Sandell LJ, Ochi T. Pro-inflammatory cytokine tumor necrosis factor-α induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem 2006, 281:27229-27241. 10.1074/jbc.M603385200, 16835229.
23. Lories RJU, Derese I, Ceuppens JL, Luyten FP. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 2003, 48:2807-2818. 10.1002/art.11389, 14558086.
24. Eyckmans J, Luyten FP. Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Eng 2006, 12:2203-2213. 10.1089/ten.2006.12.2203, 16968161.
25. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 2009, 24:274-282. 10.1359/jbmr.081003, 3276357, 18847330.
26. Taguchi K, Ogawa R, Migita M, Hanawa H, Ito H, Orimo H. The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. Biochem Biophys Res Commun 2005, 331:31-36. 10.1016/j.bbrc.2005.03.119, 15845353.
27. Haringman JJ, Kraan MC, Smeets TJM, Zwinderman KH, Tak PP. Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis. Ann Rheum Dis 2003, 62:715-721. 10.1136/ard.62.8.715, 1754636, 12860725.
28. Vieira AT, Fagundes CT, Alessandri AL, Castor MG, Guabiraba R, Borges VO, Silveira KD, Vieira EL, Gonçalves JL, Silva TA, Deruaz M, EI Proudfoot A, Sousa LP, Teixeira MM. Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis. Am J Pathol 2009, 175:2382-2391. 10.2353/ajpath.2009.090093, 2789636, 19893035.
29. Braem K, Luyten FP, Lories RJ. Blocking p38 signaling inhibits chondrogenesis in vitro, but not ankylosis in a model of ankylosing spondylitis in vivo. Ann Rheum Dis 2011, doi:10.1136/annrheumdis-2011-200377.
30. Wanders A, Heijde D, Landewé R, Béhier J-M, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum 2005, 52:1756-1765. 10.1002/art.21054, 15934081.